Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00676338
What this trial is testing

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 820
Testing effectiveness (Phase 2)Ended earlyNCT00305383
What this trial is testing

Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Bausch Health Americas, Inc. 100
Post-approval studies (Phase 4)Study completedNCT00394277
What this trial is testing

Induction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,175
Not applicableStudy completedNCT00749801
What this trial is testing

Efficacy and Safety of Geneferm Nattokinase

Who this might be right for
Hyperlipidemia
Chi Mei Medical Hospital 47
Large-scale testing (Phase 3)Study completedNCT00316719
What this trial is testing

Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
GlaxoSmithKline 105
Not applicableUnknownNCT04601701
What this trial is testing

Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.

Who this might be right for
Central Retinal Vein Occlusion
He Eye Hospital 100
Post-approval studies (Phase 4)Study completedNCT00055120
What this trial is testing

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Who this might be right for
HIV InfectionsAIDS-Related Opportunistic Infections
National Institute of Allergy and Infectious Diseases (NIAID) 283
Early research (Phase 1)Study completedNCT00033241
What this trial is testing

Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Pancreatic CancerUnspecified Adult Solid Tumor, Protocol Specific
OSI Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT02171429
What this trial is testing

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Ulcerative Colitis
Hoffmann-La Roche 358
Testing effectiveness (Phase 2)Study completedNCT02692976
What this trial is testing

Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients

Who this might be right for
Prostatic NeoplasmsImmunotherapyDendritic Cells+1 more
Radboud University Medical Center 21
Testing effectiveness (Phase 2)Ended earlyNCT02555189
What this trial is testing

Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaProstate Carcinoma Metastatic in the Bone+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 52
Post-approval studies (Phase 4)Study completedNCT01691794
What this trial is testing

Safety Sudy of Atazanavir Boosted With Ritonavir in the Treatment of HIV Infection in Pediatric Patients

Who this might be right for
HIV, Pediatric
Bristol-Myers Squibb 108
Post-approval studies (Phase 4)Study completedNCT03557437
What this trial is testing

High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment

Who this might be right for
Helicobacter Pylori Infection
Shanghai Jiao Tong University School of Medicine 216
Testing effectiveness (Phase 2)Study completedNCT00034541
What this trial is testing

Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 32
Testing effectiveness (Phase 2)Study completedNCT00073723
What this trial is testing

Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Celgene Corporation 75
Large-scale testing (Phase 3)Study completedNCT01121705
What this trial is testing

Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)

Who this might be right for
Chronic Hepatitis
Casa Sollievo della Sofferenza IRCCS 360
Testing effectiveness (Phase 2)Looking for participantsNCT03093116
What this trial is testing

Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
Turning Point Therapeutics, Inc. 500
Not applicableNot Yet RecruitingNCT07159893
What this trial is testing

Inectolizumab With Steroid Optimization in Newly Treated NMOSD

Who this might be right for
Neuromyelitis OpticaAutoimmune DiseasesDemyelinating Autoimmune Diseases, CNS
First Affiliated Hospital of Wenzhou Medical University 25
Testing effectiveness (Phase 2)Study completedNCT00615134
What this trial is testing

INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.

Who this might be right for
HIV Infections
Hoffmann-La Roche 29
Not applicableStudy completedNCT03993093
What this trial is testing

Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre

Who this might be right for
HIV InfectionsTuberculosisCandidiasis, Esophageal+3 more
Singh, Ranjan Kumar, M.D. 257
Next Page